scPharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €207.58M +20.2% €59.50M +48.7% 28.7% +0.055 pp N/A N/A
    (estimated) €172.73M +22.7% €40.01M +115.3% 23.2% +0.10 pp N/A N/A
    (estimated) €140.74M +36.6% €18.59M -244.8% 13.2% +0.26 pp €24.74M -526.5% 17.6% +0.23 pp
    (estimated) €103.05M +67.7% -€12.84M -75.1% -12.5% +0.71 pp -€5.80M -86.8% -5.6% +0.66 pp
    (estimated) €61.44M +98.3% -€51.51M -29.1% -83.8% +1.5 pp -€44.01M -26.8% -71.6% +1.2 pp
    €30.99M +167.3% -€72.63M +55.4% -234.4% +1.7 pp -€60.15M +19.1% -194.1% +2.4 pp
    €11.59M +∞% -€46.75M +46.1% -403.2% -4.0 pp -€50.50M +71.3% -435.5% -4.4 pp
    €0.00 +NaN% -€32.00M +23.1% N/A -€29.47M +27.3% N/A
    €0.00 +NaN% -€26.00M -11.4% N/A -€23.15M -2.0% N/A
    €0.00 +NaN% -€29.34M -0.1% N/A -€23.62M -9.0% N/A
    €0.00 +NaN% -€29.35M +16.9% N/A -€25.97M +5.7% N/A
    €0.00 +NaN% -€25.11M +23.6% N/A -€24.58M +28.1% N/A
    €0.00 +NaN% -€20.31M -2.3% N/A -€19.18M +45.6% N/A
    €0.00 +NaN% -€20.79M +131.8% N/A -€13.17M +60.5% N/A
    €0.00 -€8.97M N/A -€8.21M N/A

    Notifications